Due to the low prevalence of Vδ2 T cells in peripheral blood, particularly in chronically malaria-exposed individuals, we were not able to sort a sufficient number of unstimulated CD16- and CD16+ Vδ2 T cells for quantitative in vitro growth inhibition assays. The gene discussed is FCGR3A; the disease is malaria.